Search research articles
Contact Us
Filters
Showing results (251-260 of 371) with videos related to
Page
of 38
Sort By:
Rheumatology and Therapy
|
October 13, 2022
The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis
Rieke Alten, Gerd R Burmester, Marco Matucci-Cerinic, et al.
Rheumatology and Therapy
|
September 27, 2023
Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients
Rieke Alten, Gerd R Burmester, Marco Matucci-Cerinic, et al.
Joint Bone Spine
|
March 16, 2025
Diseases associated with anti-centromere protein F (anti-CENP-F) antibodies: Insights from a large cohort study
Alexandre Le Joncour, Jean-Luc Charuel, Sylvain Choquet, et al.
Arthritis Care & Research
|
September 23, 2018
Detection of Flares by Decrease in Physical Activity, Collected Using Wearable Activity Trackers in Rheumatoid Arthritis or Axial Spondyloarthritis: An Application of Machine Learning Analyses in Rheumatology
Laure Gossec, Frédéric Guyard, Didier Leroy, et al.
Seminars in Arthritis and Rheumatism
|
September 19, 2019
Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire
Elena Myasoedova, Annette De Thurah, Marie-Line Erpelding, et al.
Rheumatology (Oxford, England)
|
September 2, 2017
Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patients
Ricardo J O Ferreira, Maxime Dougados, John R Kirwan, et al.
Journal of Clinical Epidemiology
|
July 27, 2024
Building a composite score for patient self-report of flare in osteoarthritis: a comparison of methods with the Flare-OA-16 questionnaire
Fabiana Queiroga, Jonathan Epstein, Marie-Line Erpelding, et al.
BMJ Open
|
June 17, 2025
Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial
Tristan Pascart, Bruno Fautrel, Jacques-Eric Gottenberg, et al.
Arthritis Research & Therapy
|
October 24, 2009
Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients
Michel de Bandt, Bruno Fautrel, Jean Francis Maillefert, et al.
Arthritis and Rheumatism
|
April 1, 2009
Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences
Bruno Fautrel, Francis Guillemin, Olivier Meyer, et al.
Page
of 38
Search research articles
Search
Showing results (251-260 of 371) with videos related to
Sort By:
Page
of 38
Rheumatology and Therapy
|
October 13, 2022
The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis
Rieke Alten, Gerd R Burmester, Marco Matucci-Cerinic, et al.
Rheumatology and Therapy
|
September 27, 2023
Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients
Rieke Alten, Gerd R Burmester, Marco Matucci-Cerinic, et al.
Joint Bone Spine
|
March 16, 2025
Diseases associated with anti-centromere protein F (anti-CENP-F) antibodies: Insights from a large cohort study
Alexandre Le Joncour, Jean-Luc Charuel, Sylvain Choquet, et al.
Arthritis Care & Research
|
September 23, 2018
Detection of Flares by Decrease in Physical Activity, Collected Using Wearable Activity Trackers in Rheumatoid Arthritis or Axial Spondyloarthritis: An Application of Machine Learning Analyses in Rheumatology
Laure Gossec, Frédéric Guyard, Didier Leroy, et al.
Seminars in Arthritis and Rheumatism
|
September 19, 2019
Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire
Elena Myasoedova, Annette De Thurah, Marie-Line Erpelding, et al.
Rheumatology (Oxford, England)
|
September 2, 2017
Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patients
Ricardo J O Ferreira, Maxime Dougados, John R Kirwan, et al.
Journal of Clinical Epidemiology
|
July 27, 2024
Building a composite score for patient self-report of flare in osteoarthritis: a comparison of methods with the Flare-OA-16 questionnaire
Fabiana Queiroga, Jonathan Epstein, Marie-Line Erpelding, et al.
BMJ Open
|
June 17, 2025
Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial
Tristan Pascart, Bruno Fautrel, Jacques-Eric Gottenberg, et al.
Arthritis Research & Therapy
|
October 24, 2009
Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients
Michel de Bandt, Bruno Fautrel, Jean Francis Maillefert, et al.
Arthritis and Rheumatism
|
April 1, 2009
Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences
Bruno Fautrel, Francis Guillemin, Olivier Meyer, et al.
Page
of 38